While these findings suggest the potential of targeting IRE1α for the therapeutic treatment of insulin resistance and obesity, they also constitute important confounding factors that make time-course studies of high fat diet and inflammation difficult to interpret in these animal models. Here, ERN1 is linked to Insulin resistance.